Amplion Clinical Communications, Inc.

Form 483

Nashville, Tennessee, United StatesFEI 3009164985Issued September 07, 2017

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3009164985.

Observations13

Issue DateSeptember 07, 2017

StatusNo Warning Letter

Related Inspections6

Establishment Details

Firm: Amplion Clinical Communications, Inc.
Location: Nashville, Tennessee, United States
FEI Number: 3009164985
Product Type: Devices
Issue Date: September 07, 2017
Country: United States

Inspection History, 2013 to 2023

NAI2

VAI3

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Amplion Clinical Communications, Inc. FDA Form 483, Nashville, Tennessee, September 7, 2017